Le Lézard
Classified in: Health, Science and technology, Business
Subject: BOARD OF DIRECTORS

Helix BioPharma Corp. Director Resigns


TORONTO, ONTARIO--(Marketwired - July 17, 2017) - Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Board has accepted Mr. Albert Beraldo's resignation as director of the Company and Audit Committee Chair, effective July 14, 2017. Mr. Beraldo has conveyed to the Board that his other commitments have become too great for him to be able to fulfill the requirements of his position on the Board and determined it best for him to step down and make room for someone with the time and energy to devote to the Board and the Company.

"On behalf of the Board and management of Helix, I would like to thank Albert for his time and dedication and we wish him well in his future business ventures," said Dr. Sven Rohmann Chairman of Helix.

About Helix BioPharma Corp.

Helix BioPharma Corp. is an immuno-oncology company specializing in the field of cancer therapy. The company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its novel L-DOS47 new drug candidate. Helix is currently listed on the TSX and FSE under the symbol "HBP".


These press releases may also interest you

at 13:10
Bilateral Chamber, a leading organization at the forefront of global commerce, hosted His Excellency Mohammed Shyaa Sabbar Al-Sudani, Prime Minister of the Republic of Iraq and his delegation yesterday in Houston, Texas. The Iraqi Prime Minister was...

at 13:05
Versa Networks, the global leader in AI/ML-powered Unified Secure Access Service Edge (SASE) and Software Defined WAN (SD-WAN), today announced it is recognized in the Gartner Magic Quadrant for Security Service Edge (SSE) which will help buyers...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:59
Fusion Academy, the world's most personalized school with one-to-one classes to match students' pace and preference, is pleased to announce its 2024 Spring Virtual College Week, taking place from April 22 to April 25. This unique online program is...

at 12:55
Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of its client S&L Computer Services, Inc. to Cyber Advisors (a portfolio company of Goldner Hawn). The acquisition...

at 12:45
Beaverlab today announced the launch of a Kickstarter campaign for its new Excope DT1 camera. Excope DT1 is the world's lightest, portable super-telephoto camera for photos and videos. It is versatile, relieving photographers from the hassle of...



News published on and distributed by: